Outpatient Management of Obscure Gastrointestinal Bleeding: A New Perspective in High-risk Patients

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2024 May 31

PMID 38817662

Authors

Maria Elena Riccioni

Clelia Marmo

Affiliations

Soon will be listed here.

Abstract

Mid-gastrointestinal bleeding accounts for approximately 5%-10% of all gastrointestinal bleeding cases, and vascular lesions represent the most frequent cause. The rebleeding rate for these lesions is quite high (about 42%). We hereby recommend that scheduled outpatient management of these patients could reduce the risk of rebleeding episodes.

References

Al-Samkari H, Kasthuri R, Parambil J, Albitar H, Almodallal Y, Vazquez C . An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica. 2020; 106(8):2161-2169. PMC: 8327711. DOI: 10.3324/haematol.2020.261859. View

Otani K, Shimada S, Watanabe T, Nadatani Y, Higashimori A, Ominami M . Long-term rebleeding rate and predictive factors of rebleeding after capsule endoscopy in patients with obscure GI bleeding. Gastrointest Endosc. 2022; 96(6):956-969.e3. DOI: 10.1016/j.gie.2022.07.012. View

Baba Y, Kawano S, Kono Y, Inokuchi T, Kanzaki H, Iwamuro M . Clinical Characteristics and Risk Factors for Rebleeding in Patients with Obscure Gastrointestinal Bleeding. Intern Med. 2020; 59(11):1345-1350. PMC: 7332634. DOI: 10.2169/internalmedicine.3628-19. View

Bucci C, Marmo C, Soncini M, Riccioni M, Laursen S, Gralnek I . The interaction of patients' physical status and time to endoscopy on mortality risk in patients with upper gastrointestinal bleeding: A national prospective cohort study. Dig Liver Dis. 2023; 56(6):1095-1100. DOI: 10.1016/j.dld.2023.11.024. View

M El-Halabi M, Green M, Jones C, Salyers Jr W . Under-diagnosing and under-treating iron deficiency in hospitalized patients with gastrointestinal bleeding. World J Gastrointest Pharmacol Ther. 2016; 7(1):139-44. PMC: 4734947. DOI: 10.4292/wjgpt.v7.i1.139. View

Goltstein L, Grooteman K, Rocco A, Holleran G, Frago S, Salgueiro P . Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021; 6(11):922-932. DOI: 10.1016/S2468-1253(21)00262-4. View

Gerson L, Fidler J, Cave D, Leighton J . ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroenterol. 2015; 110(9):1265-87. DOI: 10.1038/ajg.2015.246. View

Bager P, Dahlerup J . Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage--a placebo-controlled study. Aliment Pharmacol Ther. 2013; 39(2):176-87. DOI: 10.1111/apt.12556. View

Ohmiya N, Nakamura M, Osaki H, Yamada H, Tahara T, Nagasaka M . Development of a Comorbidity Index to Identify Patients With Small Bowel Bleeding at Risk for Rebleeding and Small Bowel Vascular Diseases. Clin Gastroenterol Hepatol. 2018; 17(5):896-904.e4. DOI: 10.1016/j.cgh.2018.08.034. View

10.

Romeo S, Neri B, Mossa M, Riccioni M, Scucchi L, Sena G . Diagnostic yield of small bowel capsule endoscopy in obscure gastrointestinal bleeding: a real-world prospective study. Intern Emerg Med. 2021; 17(2):349-358. PMC: 8964573. DOI: 10.1007/s11739-021-02791-z. View

11.

Chang A, Rugivarodom M, Pungpipattrakul N, Akarapatima K, Suwanno K, Rattanasupar A . Role of oral iron supplementation for anemia secondary to acute nonvariceal upper gastrointestinal bleeding: a randomized controlled trial. J Gastroenterol Hepatol. 2023; 38(8):1283-1291. DOI: 10.1111/jgh.16185. View

12.

Ferrer-Barcelo L, Sanchis Artero L, Sempere Garcia-Arguelles J, Canelles Gamir P, Gisbert J, Ferrer-Arranz L . Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding. Aliment Pharmacol Ther. 2019; 50(3):258-268. PMC: 6771644. DOI: 10.1111/apt.15327. View

13.

Khan A, Gupta K, Chowdry M, Sharma S, Maheshwari S, Patel C . Thirty-day readmission rates, reasons, and costs for gastrointestinal angiodysplasia-related bleeding in the USA. Eur J Gastroenterol Hepatol. 2021; 34(1):11-17. DOI: 10.1097/MEG.0000000000002027. View

14.

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z . Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia. N Engl J Med. 2023; 389(18):1649-1659. DOI: 10.1056/NEJMoa2303706. View

15.

Kim Y, Kim J, Kang E, Park S, Park J, Cheon J . Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study. Diagnostics (Basel). 2022; 12(4). PMC: 9027880. DOI: 10.3390/diagnostics12040954. View